Adverum Biotechnologies Inc (ADVM) Company Profile & Statistics

Adverum Biotechnologies Inc
ADVM
(Nasdaq - US)
N/A
10.40
+0.40 (+4.00%)
in:usd•As of: May 03, 2024 13:25 UTC -4
Open
10.14
High
10.59
Low
10.14

About Adverum Biotechnologies Inc

CEO

Laurent Fischer

Headquarters

100 cardinal way

redwood city, ca 94063, united states

Auditor

Ernst & Young LLP

Employees

121

Share Holders

Website

http://www.adverum.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum?s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control.

Adverum Biotechnologies Inc Statistics

Valuation Measures

Market Capitalization ²	215.80M
Enterprise Value	140.80M
Enterprise Value/EBITDA (ttm)	-1.17
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.18
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-201.78%
Return on Equity (ttm)	-98.65%
Return on Invested Capital (ttm)	-102.87%
Return on Assets (ttm)	-52.85%

Income Statement

Revenue (ttm)	3.60M
Revenue Per Share (ttm)	0.17
Gross Profit (ttm)	3.60M
EBITDA (ttm)³	-120.28M
Net Income Avi to Common (ttm)	-117.16M
Diluted EPS (ttm)	-11.60

Share Statistics

Beta (5Y Monthly)	0.89
52-Week Change	35.06%
S&P500 52-Week Change	26.46%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	20.75M
Dividend Yield	0.00%
Float ⁴	19.66M
% Held by Insiders	5.30%
% Held by Institutions	48.17%

Balance Sheet

Total Cash (mrq)	96.53M
Total Cash Per Share (mrq)	4.65
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.13%
Quick Ratio (mrq)	4.13%
Book Value Per Share (mrq)	8.23

Cash Flow

Operating Cash Flow Per Share (ytd)	-9.02
Free Cash Flow (ytd)	-91.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Adverum Biotechnologies Inc

Trade With A Regulated Broker